|Description||SS5020 is a novel benzopyran antiestrogen and it exhibits no genotoxic activity to damage DNA. In addiction, SS5020 does not present significant uterotrophic potential in rats. SS5020 had stronger antitumor potential than those same antiestrogens against 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats when using the human equivalent molar dose of TAM.|
|Synonyms||SS5020; SS5020; SS 5020. (E)-3-(4-((7-hydroxy-2-oxo-3-phenyl-2H-chromen-4-yl)methyl)phenyl)acrylic acid|
|Solubility||Soluble in DMSO|
|Quality Standard||In-house standard|
|Shelf Life||2 month in rt, long time|
Glafenine hydrochloride, an anthranilic acid derivative, is a non-narcotic analgesic and non-steroidal anti-inflammatory drug. It is an ABCG2 inhibitor (IC50= 3...
NAI-N3 is a novel RNA acylation reagent that enables RNA purification.
TAT-Gap19 is a brain penetrating Cx43 hemichannel blocker (IC50 ~7 μM) with no significant affinity for gap junctions or Panx1 channels.
N-desmethyl Netupitant is a metabolite of an antiemitic drug called Netupitant.
This active molecular is a bio-active chemical and detailed information has not been published yet
Hydroxy Iloperidone, produced through metabolism of Iloperidone, could have probable antipsychotic effect.
Galnon is a non-peptide galanin GAL1 and GAL2 receptor agonist (Ki = 11.7 and 34.1 μM, respectively) with anticonvulsant, anxiolytic, anorectic and amnestic act...
Ro 41-3290, a desethylated metabolite of Ro 41-3696, has shown to be also a partial agonist at the benzodiazepine receptor.